Publication | Closed Access
ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)
130
Citations
18
References
2010
Year
Low-dose intravitreal infliximab was not well tolerated in this small group of patients and was both immunogenic and probably retinotoxic.
| Year | Citations | |
|---|---|---|
Page 1
Page 1